news
Measures to accelerate market access for innovative medicines discussed at SPIEF
The development and production of innovative medicines are among the key priorities of the Russian Pharmaceutical Industry Development Strategy through 2030
RANEPA and Petrovax Pharm to Assess the Pharmaceutical Industry’s Contribution to Russia’s Economic and Scientific Development
Petrovax Pharm and the Union of Russian Pediatricians sign agreement at SPIEF to promote a culture of vaccination
Petrovax Pharm announces support program for women with aggressive breast cancer at SPIEF
Pharma marketing in a new reality: which promotion channels still deliver results
Russian pharmaceutical manufacturers scale up full-cycle production of oncology products and call for faster patient access
Localized full-cycle production of a vital oncology medicine launched in Russia
Eurasian Society for Infectious Diseases includes Polyoxidonium® in new recommendations for the treatment of ARVI in children
Russian pharma needs a fast-track pathway for innovative medicines
